OTC Markets OTCQB - Delayed Quote USD
NervGen Pharma Corp. (NGENF)
2.1300
-0.0200
(-0.93%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-16,841.0340
-16,841.0340
-11,295.5940
-17,784.1630
-8,269.1570
Investing Cash Flow
58.8740
58.8740
-138.8540
-21.1050
-45.0850
Financing Cash Flow
22,695.1110
22,695.1110
766.2850
22,641.4350
19,613.1620
End Cash Position
17,267.4890
17,267.4890
11,659.5440
22,451.5990
16,928.8570
Capital Expenditure
-21.1040
--
-141.4030
-21.1050
-45.0850
Issuance of Capital Stock
23,011.7880
23,011.7880
--
19,762.8110
18,901.6110
Repayment of Debt
-100.9260
-100.9260
-100.9260
-75.6950
--
Free Cash Flow
-16,841.0340
-16,841.0340
-11,436.9970
-17,805.2680
-8,314.2420
12/31/2021 - 4/3/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%
MSCLF Satellos Bioscience Inc.
0.5020
0.00%
NYMXF Nymox Pharmaceutical Corporation
0.1178
0.00%
RZLT Rezolute, Inc.
3.9700
+27.65%
DRMA Dermata Therapeutics, Inc.
0.7924
+13.20%
BETRF BetterLife Pharma Inc.
0.0680
0.00%
APTOF Aptose Biosciences Inc.
2.3100
-6.48%
ACHV Achieve Life Sciences, Inc.
2.4300
-2.02%
GANX Gain Therapeutics, Inc.
1.8500
0.00%